Stephen P Macmillan - Net Worth and Insider Trading

Stephen P Macmillan Net Worth

The estimated net worth of Stephen P Macmillan is at least $209 Million dollars as of 2024-12-26. Stephen P Macmillan is the Chairman, President and CEO of Hologic Inc and owns about 2,304,391 shares of Hologic Inc (HOLX) stock worth over $168 Million. Stephen P Macmillan is also the President & CEO of Stryker Corp and owns about 112,586 shares of Stryker Corp (SYK) stock worth over $42 Million. Details can be seen in Stephen P Macmillan's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Stephen P Macmillan has not made any transactions after 2024-07-30 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Stephen P Macmillan

To

Stephen P Macmillan Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Stephen P Macmillan owns 7 companies in total, including Boston Scientific Corp (BSX) , Hologic Inc (HOLX) , and Alere Inc (ALR) among others .

Click here to see the complete history of Stephen P Macmillan’s form 4 insider trades.

Insider Ownership Summary of Stephen P Macmillan

Ticker Comapny Transaction Date Type of Owner
BSX Boston Scientific Corp 2019-05-09 director
HOLX Hologic Inc 2024-07-30 director & President and CEO
ALR Alere Inc 2013-10-31 director
LIMIT LIMIT 2008-09-18 director
LIMIT LIMIT 2005-10-21 director & President & CEO
LIMIT LIMIT 2013-08-14 director
LIMIT LIMIT 2023-06-01 director

Stephen P Macmillan Latest Holdings Summary

Stephen P Macmillan currently owns a total of 2 stocks. Among these stocks, Stephen P Macmillan owns 2,304,391 shares of Hologic Inc (HOLX) as of July 30, 2024, with a value of $168 Million and a weighting of 80.12%. Stephen P Macmillan also owns 112,586 shares of Stryker Corp (SYK) as of October 21, 2005, with a value of $42 Million and a weighting of 19.88%.

Latest Holdings of Stephen P Macmillan

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
HOLX Hologic Inc 2024-07-30 2,304,391 72.72 167,575,314
SYK Stryker Corp 2005-10-21 112,586 369.40 41,589,268

Holding Weightings of Stephen P Macmillan


Stephen P Macmillan Form 4 Trading Tracker

According to the SEC Form 4 filings, Stephen P Macmillan has made a total of 7 transactions in Hologic Inc (HOLX) over the past 5 years, including 0 buys and 7 sells. The most-recent trade in Hologic Inc is the sale of 44,039 shares on July 30, 2024, which brought Stephen P Macmillan around $4 Million.

According to the SEC Form 4 filings, Stephen P Macmillan has made a total of 0 transactions in Stryker Corp (SYK) over the past 5 years. The most-recent trade in Stryker Corp is the acquisition of 5,000 shares on October 21, 2005, which cost Stephen P Macmillan around $201,850.

Insider Trading History of Stephen P Macmillan

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Stephen P Macmillan Trading Performance

GuruFocus tracks the stock performance after each of Stephen P Macmillan's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Stephen P Macmillan is 8.51%. GuruFocus also compares Stephen P Macmillan's trading performance to market benchmark return within the same time period. The performance of stocks bought by Stephen P Macmillan within 3 months outperforms 2 times out of 3 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Stephen P Macmillan's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Stephen P Macmillan

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
3 out of 3 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 5.83 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 1.31 LIMIT LIMIT LIMIT LIMIT LIMIT

Stephen P Macmillan Ownership Network

Ownership Network List of Stephen P Macmillan

No Data

Ownership Network Relation of Stephen P Macmillan

Insider Network Chart

Stephen P Macmillan Owned Company Details

What does Boston Scientific Corp do?

Who are the key executives at Boston Scientific Corp?

Stephen P Macmillan is the director of Boston Scientific Corp. Other key executives at Boston Scientific Corp include SVP & Human Resources Wendy Carruthers , SVP&Pres & Endoscopy Arthur C Butcher , and SVP & Glob Ops & Qual John Bradley Sorenson .

Boston Scientific Corp (BSX) Insider Trades Summary

Over the past 18 months, Stephen P Macmillan made no insider transaction in Boston Scientific Corp (BSX). Other recent insider transactions involving Boston Scientific Corp (BSX) include a net sale of 139,857 shares made by Wendy Carruthers , a net sale of 144,352 shares made by Jeffrey B. Mirviss , and a net sale of 828,398 shares made by Michael F Mahoney .

In summary, during the past 3 months, insiders sold 529,834 shares of Boston Scientific Corp (BSX) in total and bought 0 shares, with a net sale of 529,834 shares. During the past 18 months, 1,721,679 shares of Boston Scientific Corp (BSX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,721,679 shares.

Boston Scientific Corp (BSX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Boston Scientific Corp Insider Transactions

No Available Data

Stephen P Macmillan Mailing Address

Above is the net worth, insider trading, and ownership report for Stephen P Macmillan. You might contact Stephen P Macmillan via mailing address: 250 Campus Drive, Marlborough Ma 01752.

Discussions on Stephen P Macmillan

No discussions yet.